Costs of Cutting Weight—An Economic Evaluation of GLP-1 Agonists vs Gastric Bypass
Year: 2025
Type: article
Abstract: This economic evaluation compares the long-term cost-effectiveness of glucagon-like peptide-1 (GLP-1) receptor agonists vs Roux-en-Y gastric bypass.
Source: JAMA Surgery
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4415436370
